|
Volumn 5, Issue 2, 2002, Pages 46-52
|
Down syndrome and major depressive disorder: A review
|
Author keywords
Bipolar disorder; Depression; Down syndrome; ECT; SSRI; Suicide
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
AMITRIPTYLINE;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
CARBAMAZEPINE;
DESIPRAMINE;
LITHIUM CARBONATE;
MACROGLOBULIN;
SEROTONIN;
SEROTONIN AGONIST;
SEROTONIN UPTAKE INHIBITOR;
THYROID HORMONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VALPROIC ACID;
ALZHEIMER DISEASE;
ANOREXIA NERVOSA;
AUTONOMIC DYSFUNCTION;
BEHAVIOR THERAPY;
CLINICAL FEATURE;
COGNITIVE THERAPY;
COMORBIDITY;
DEMENTIA;
DEPRESSION;
DIAGNOSTIC ACCURACY;
DIFFERENTIAL DIAGNOSIS;
DISEASE ASSOCIATION;
DOWN SYNDROME;
ELECTROCONVULSIVE THERAPY;
EVIDENCE BASED MEDICINE;
GROUP THERAPY;
HALLUCINATION;
HIGH RISK POPULATION;
HUMAN;
HYPOTHYROIDISM;
LONG TERM CARE;
MANIC DEPRESSIVE PSYCHOSIS;
MEDICAL LITERATURE;
MENTAL DEFICIENCY;
MENTAL DISEASE;
NEUROBIOLOGY;
NEUROLOGIC DISEASE;
NEUROPSYCHOLOGICAL TEST;
PATIENT ATTITUDE;
PRACTICE GUIDELINE;
PREVALENCE;
PROGNOSIS;
PSYCHOSIS;
QUALITY OF LIFE;
REVIEW;
SEROTONIN BLOOD LEVEL;
SUICIDE;
SYMPTOMATOLOGY;
|
EID: 0036274680
PISSN: 10573291
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (11)
|
References (44)
|